scispace - formally typeset
K

Kei Tobiume

Researcher at Tokyo Medical and Dental University

Publications -  11
Citations -  5915

Kei Tobiume is an academic researcher from Tokyo Medical and Dental University. The author has contributed to research in topics: ASK1 & MAP kinase kinase kinase. The author has an hindex of 8, co-authored 9 publications receiving 5654 citations. Previous affiliations of Kei Tobiume include Japanese Foundation for Cancer Research.

Papers
More filters
Journal ArticleDOI

Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.

TL;DR: Evidence that Trx is a negative regulator of ASK1 suggests possible mechanisms for redox regulation of the apoptosis signal transduction pathway as well as the effects of antioxidants against cytokine‐ and stress‐induced apoptosis.
Journal ArticleDOI

ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis

TL;DR: It is shown that by deleting ASK1 in mice, TNF‐ and H2O2‐induced sustained activations of JNK and p38 are lost inASK1−/− embryonic fibroblasts, and that ASK 1−-/− cells are resistant to TNF- and H1N1‐induced apoptosis.
Journal ArticleDOI

Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer.

TL;DR: It is shown that phosphorylation of Thr845 at the activation loop is essential for ASK1 to be activated by H2O2, and it is proposed that this potential Thr8 45 kinase may be an ignition kinase that triggers Thr 845 phosphorylated in oligomerized and activation‐competent forms of AsK1.
Journal ArticleDOI

Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

TL;DR: PP5 appears to act as a physiological inhibitor of ASK1–JNK/p38 pathways by negative feedback and inhibited not only H2O2‐induced sustained activation of AsK1 but also ASK 1‐dependent apoptosis.